drugset / Trial / NCT05189717
A Trial of HRS-8080 Tablets in Metastatic or Local Advanced Breast Cancer of Adults
NaSingle-groupOpen-labelTreatment
Summary
The study is being conducted to evaluate the tolerance, and safety of HRS-8080 tablets monotherapy and combined with other anti-cancer therapy for metastatic or local advanced breast cancer in adults. To explore the reasonable dosage of HRS-8080 tablets for metastatic or local advanced breast cancer.
Timeline
- Start
- 2022-02-17
- Primary completion
- 2024-10-31
- Completion
- 2025-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-8080 | Unknown | — | — |
| Background | Abemaciclib | Small molecule | — | — |
| Background | Dalpiciclib | Small molecule | — | — |
| Background | Everolimus | Small molecule | — | — |